Raffa Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.2K | Hold |
106
| – | – | ﹤0.01% | 288 |
|
|
2026
Q1 | $17.9K | Hold |
106
| – | – | ﹤0.01% | 288 |
|
|
2025
Q4 | $17.9K | Buy |
+106
| New | +$17.2K | ﹤0.01% | 279 |
|
|
2025
Q2 | – | Sell |
-2,479
| Closed | -$317K | – | 1119 |
|
|
2025
Q1 | $317K | Hold |
2,479
| – | – | 0.07% | 63 |
|
|
2024
Q4 | $328K | Hold |
2,479
| – | – | 0.08% | 62 |
|
|
2024
Q3 | $361K | Hold |
2,479
| – | – | 0.09% | 60 |
|
|
2024
Q2 | $340K | Hold |
2,479
| – | – | 0.1% | 65 |
|
|
2024
Q1 | $340K | Hold |
2,479
| – | – | 0.1% | 62 |
|
|
2023
Q4 | $337K | Hold |
2,479
| – | – | 0.1% | 58 |
|
|
2023
Q3 | $303K | Hold |
2,479
| – | – | 0.1% | 54 |
|
|
2023
Q2 | $315K | Buy |
2,479
+311
| +14% | +$40.4K | 0.11% | 54 |
|
|
2023
Q1 | $280K | Buy |
+2,168
| New | +$284K | 0.1% | 56 |
|
|
2022
Q4 | – | Sell |
-392
| Closed | -$45.8K | – | 1108 |
|
|
2022
Q3 | $45.8K | Hold |
392
| – | – | 0.02% | 142 |
|
|
2022
Q2 | $46.1K | Hold |
392
| – | – | 0.02% | 145 |
|
|
2022
Q1 | $51.1K | Hold |
392
| – | – | 0.02% | 146 |
|
|
2021
Q4 | $59.8K | Buy |
+392
| New | +$60.7K | 0.02% | 131 |
|
|
2017
Q4 | – | Sell |
-120
| Closed | -$13.3K | – | 272 |
|
|
2017
Q3 | $13.3K | Hold |
120
| – | – | 0.01% | 189 |
|
|
2017
Q2 | $12.4K | Hold |
120
| – | – | 0.01% | 189 |
|
|
2017
Q1 | $11.7K | Hold |
120
| – | – | 0.01% | 167 |
|
|
2016
Q4 | $10.6K | Hold |
120
| – | – | 0.01% | 173 |
|
|
2016
Q3 | $11.6K | Hold |
120
| – | – | 0.01% | 168 |
|
|
2016
Q2 | $10.3K | Hold |
120
| – | – | 0.01% | 169 |
|
|
2016
Q1 | $10.4K | Hold |
120
| – | – | 0.01% | 176 |
|
|
2015
Q4 | $13.5K | Hold |
120
| – | – | 0.01% | 156 |
|
|
2015
Q3 | $12.1K | Hold |
120
| – | – | 0.01% | 158 |
|
|
2015
Q2 | $14.8K | Hold |
120
| – | – | 0.01% | 146 |
|
|
2015
Q1 | $13.7K | Hold |
120
| – | – | 0.01% | 129 |
|
|
2014
Q4 | $12.1K | Hold |
120
| – | – | 0.01% | 130 |
|
|
2014
Q3 | $10.9K | Hold |
120
| – | – | 0.01% | 136 |
|
|
2014
Q2 | $10.3K | Hold |
120
| – | – | 0.01% | 133 |
|
|
2014
Q1 | $9.46K | Hold |
120
| – | – | 0.01% | 135 |
|
|
2013
Q4 | $12.1K | Buy |
+120
| New | +$8.51K | 0.01% | 130 |
|
Other funds holding IBB
CB
Raffa Wealth Management's IBB Position: Q2 2026 in Review
Raffa Wealth Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 106 shares worth $20.2K. The position accounts for ﹤0.01% of the portfolio, ranked #288.
Raffa Wealth Management first reported a position in IBB in Q4 2013 and has held it in 32 quarters since. The position peaked at $361K in Q3 2024. 926 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Raffa Wealth Management held 106 shares of iShares Biotechnology ETF worth $20.2K as of Q2 2026.
- Raffa Wealth Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
- iShares Biotechnology ETF made up ﹤0.01% of Raffa Wealth Management's portfolio in Q2 2026, its #288 holding.
- Raffa Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2013 and has held it in 32 quarters since.
- Raffa Wealth Management's iShares Biotechnology ETF position peaked at $361K in Q3 2024.
- 926 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.